Referral quality

The best surgical referral in 2027 is a documented failure.

MSKvalue Insights · July 2026 · For surgery-center and MSK service-line leaders

Every MSK service line measures referrals by volume. Almost none measure them by the thing that actually determines whether a case reaches the OR on schedule: whether the patient arrives with a record that satisfies the payer. That distinction is about to get expensive, because the value-based models arriving in 2027 change who is producing that record — and it is not you.

Coverage has always turned on documented failure

Payers do not authorise a knee or hip replacement because a patient hurts. They authorise it because the chart shows that appropriate non-operative care was tried and did not work. Medicare Advantage prior-authorisation policies and the local coverage determinations that govern arthroplasty are built on that premise — typically a period of supervised conservative management, commonly three months or more, documented before the procedure, with the response recorded. Missing or thin documentation of that trial is one of the most reliable ways to turn a clinically obvious case into a delayed one.

The authorisation is not a test of whether surgery is appropriate. It is a test of whether your chart can prove surgery is appropriate. Those are different problems, and only the second one is administrative.

What changes in 2027

Two things arrive at once. The Ambulatory Specialty Model begins January 1, 2027, mandatory, with low back pain as a launch cohort and up to ±9% of Part B at stake per physician. And CMS’s value-based musculoskeletal arrangements put attributed patients inside multi-month care periods in which conservative management is not a formality — it is the product, and it is measured. Patient-reported outcomes on a defined schedule. KOOS JR, HOOS JR, Oswestry. Pain intensity. Global impression of change.

Which means a program running a twelve-month care period generates, as an ordinary byproduct, a cohort of patients with twelve months of supervised, outcome-measured conservative care that demonstrably did not work. Four times the documentation bar that coverage requires, collected on a schedule the payer itself defined, in instruments the payer itself recognises.

Why that patient is worth more than three ordinary referrals

Consider what usually shows up. Published data from a large academic system found that of musculoskeletal patients, only about 16% received a physical-therapy referral, and only about 24% of those attended — roughly four in a hundred MSK patients actually reach PT. The drop-off was driven mostly by structural factors: distance, payer type, where the referral originated. Most patients who arrive at a surgical consult therefore have some history of conservative care and almost no record of it, which is precisely the gap your prior-auth staff spends its week closing retroactively.

The value-based non-responder inverts that. Clinical appropriateness and administrative readiness arrive together, in one patient, at the moment conservative care has genuinely been exhausted. For a service line whose bottleneck is authorisation turnaround rather than lead flow, that is not an incremental improvement in referral quality. It is a different category of referral.

The timing rule, which most people get backwards

The intuitive move — identify the patient who is clearly not improving at month four and route them to a surgeon — is wrong, and it is wrong in both directions. Clinically, it truncates a trial the coverage standard expects to see completed. Financially, value-based MSK arrangements penalise substitute services delivered to an attributed patient mid-period, so early routing costs the referring program money. The cohort that works is the one that finished and did not improve. Any program leader you approach will already know this; showing that you know it is most of the credibility in the first conversation.

And the structure has to be clean. A referral relationship between a value-based MSK program and a surgical facility touches the Anti-Kickback Statute and Stark directly. Flat or fair-market-value terms, written, disclosed, never per-referral or volume-linked, reviewed by healthcare counsel before the first patient moves. A referral channel that cannot survive an OIG reading is a liability with revenue attached.

What a service-line leader does about it

Measure authorisation turnaround by referral source. If you cannot say which sources produce clean approvals and which produce three rounds of records requests, you cannot tell a good referral from a loud one. See how that becomes a service-line process.
Find the value-based MSK programs in your market. Employer-sponsored MSK vendors, MA plan programs, and the CMS models attributing MSK patients regionally. Ask each one what happens to the patients who complete a care period without improving. Most have no answer, which is the opening.
Make the intake accept the record, not just the patient. A PROM history arriving as a PDF fax is a record you will re-key. Structured intake is what turns their documentation into your authorisation.
Instrument your own side first. Under ASM the conservative-care patient is scored work for your surgeons too — surgeon-side outcome and billing instrumentation (surgeonvalue.com) is how a physician walks into the peer curve with their own evidence rather than CMS’s reconstruction of it.
Do the counsel work before the pipeline, not after. The arrangement is easy to structure at zero patients and painful to restructure at fifty.

The centres that win the next three years will not be the ones with the most referrals. They will be the ones whose referrals arrive already able to prove they belong.

Start the conversation →

Coverage criteria vary by payer, plan, and MAC jurisdiction; verify against current policy. Not clinical, legal, or financial advice. Referral-source statistics: Sharpe JA et al., Family Practice 2021;38(3):203–209. MSKvalue assembles independent best-of-class products with the American Joint Replacement Registry as the outcomes backbone.